Kaken Pharmaceutical (4521) · InitiativeAdvanced
Construction of a fermentation-based agricultural chemical active ingredient plant
First written in FY2025-H1. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Construction and expansion of the fermentation-based agrochemical active-ingredient plant at the Shizuoka PlantA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「May 2025 Fermentation active ingredient building completed at the Shizuoka Plant. Shizuoka site Pharmaceuticals Rebuilding Agricultural chemical production facilities (including ancillary facilities) 12,300 687 Internal funds November 2025 FY2027 onward Expansion of production capacity」
The fermentation active ingredient building was completed in May 2025, and some facilities began operating in August 2025. In addition, a ¥12,300 million rebuilding and expansion plan for agricultural chemical production facilities was launched. - FY2025-H1First statedAnnual report
「The Company decided to construct a manufacturing plant for fermentation-based agricultural chemical active ingredients at the Group’s Shizuoka Plant.」
In anticipation of expanding demand for Polyoxin in Europe, the United States and other markets, the Company decided to construct a manufacturing plant for fermentation-based agricultural chemical active ingredients at the Shizuoka Plant. This is a new capital investment initiative for the agricultural chemicals production platform.